Immune Implications of Cholesterol-Containing Lipid Nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Clinically approved nanoparticle therapeutics predominantly utilize lipid nanoparticles (LNPs), often incorporating cholesterol.
• Macrophage uptake of LNPs influences drug pharmacokinetics, with macrophages possessing enzymes to metabolize cholesterol.
• Oxysterols, cholesterol oxidation products, possess immune-modulatory effects and are implicated in diseases.

Purpose of the Study:

• To review the cellular uptake, trafficking, metabolism, and immune modulation of cholesterol-associated nanoparticles.
• To elucidate the in vivo metabolic fate of cholesterol within lipid nanoparticles.
• To identify knowledge gaps crucial for developing safer and more effective LNP-based therapeutics.

Main Methods:

• Literature review focusing on cellular mechanisms of nanoparticle interaction.
• Analysis of macrophage metabolism of cholesterol and its oxidation products.
• Comparison with endogenous lipoprotein metabolism relevant to nanoparticle-associated cholesterol.

Main Results:

• Macrophages readily engulf LNPs and possess the enzymatic machinery to convert LNP cholesterol into oxysterols.
• Oxysterols derived from LNPs may exert immune-modulatory effects, influencing therapeutic outcomes.
• The in vivo metabolic fate and immune consequences of LNP-associated cholesterol remain largely uncharacterized.

Conclusions:

• Understanding the in vivo metabolism of LNP-associated cholesterol is critical for LNP-drug development.
• Further research is needed to address knowledge gaps regarding oxysterol formation and immune modulation by LNPs.
• This knowledge is essential for designing safer and more effective lipid nanoparticle delivery systems.